PMD Device Solutions Past Earnings Performance
Past criteria checks 0/6
PMD Device Solutions's earnings have been declining at an average annual rate of -17.5%, while the Biotechs industry saw earnings growing at 10.1% annually. Revenues have been growing at an average rate of 60% per year.
Key information
-17.5%
Earnings growth rate
98.5%
EPS growth rate
| Biotechs Industry Growth | -14.6% |
| Revenue growth rate | 60.0% |
| Return on equity | n/a |
| Net Margin | -109.7% |
| Next Earnings Update | 22 Nov 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How PMD Device Solutions makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 40 | -44 | 57 | 0 |
| 31 Mar 24 | 37 | -39 | 51 | 0 |
| 31 Dec 23 | 38 | -39 | 52 | 0 |
| 31 Mar 23 | 18 | -36 | 33 | 0 |
Quality Earnings: 8T00 is currently unprofitable.
Growing Profit Margin: 8T00 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if 8T00's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare 8T00's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 8T00 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-3.1%).
Return on Equity
High ROE: 8T00's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.